IPCA-ESCITALOPRAM escitalopram (as oxalate) 20 mg tablet blister

Active ingredient:

escitalopram oxalate, Quantity: 25.47 mg

Available from:

Ipca Pharma (Australia) Pty Ltd

INN (International Name):

escitalopram oxalate

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: macrogol 400; titanium dioxide; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; hypromellose; microcrystalline cellulose; purified talc

Administration route:

Oral

Units in package:

28, 14, 98, 56

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Treatment of major depression.,Treatment of social anxiety disorder (social phobia).,Treatment of generalised anxiety disorder.,Treatment of obsessive-compulsive disorder.

Product summary:

Visual Identification: White to off-white, oval, biconvex, film-coated tablet with 'C3' embossed on one side and a notch break-line on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 48 Months; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2012-09-25